Status | In progress |
Technology type | Procedure |
Decision | Selected |
Process | IP |
ID number | 1701 |
Description | Prostatic urethral temporary implant insertion aims to relieve symptoms of benign prostatic hyperplasia by creating new channels in the urethra to allow urine to exit the bladder without having the complications of an implant left in situ. It may also reduce the risk of sexual dysfunction. Using local anaesthesia and light sedation, a folded nitinol device is inserted into the prostatic urethra with a cystoscope under direct visualisation. Over the following days, the device deploys in the urethra and the pressure applied by its 3 struts makes ischemic incisions in the prostate and bladder neck and creates new longitudinal channels through which urine can flow. After 5 to 7 days, the device is removed using lidocaine gel and a flexible silicone catheter inserted into the urethra. Both insertion and removal of the device are done as a day case procedure and take about 5 minutes. |
Provisional Schedule
IPAC 2 | 14 July 2022 |
Expected publication | 21 September 2022 |
Email enquiries
- If you have any queries please email ip@nice.nhs.uk
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
24 March 2022 - 25 April 2022 | Interventional procedure consultation |
10 February 2022 | IPAC 1 |
For further information on how we develop interventional procedures guidance, please see our IP manual